Entinostat and Anastrozole in Treating Postmenopausal Women With TNBC That Can Be Removed by Surgery
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Estrogen Receptor-negative Breast Cancer|HER2-negative Breast Cancer|Progesterone Receptor-negative Breast Cancer|Stage I Breast Cancer|Stage II Breast Cancer|Stage IIIA Breast Cancer|Triple-negative Breast Cancer
Interventions: DRUG: entinostat|DRUG: anastrozole|OTHER: diagnostic laboratory biomarker analysis|PROCEDURE: therapeutic conventional surgery
Sponsor: University of Maryland, Baltimore
Collaborators: Syndax Pharmaceuticals